Mettler-Toledo International, Inc. (NYSE:MTD) Receives $1,435.42 Average PT from Brokerages

Mettler-Toledo International, Inc. (NYSE:MTD) has been given an average recommendation of “Moderate Buy” by the thirteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $1,463.75.

A number of equities analysts have commented on MTD shares. Weiss Ratings reissued a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 29th. Bank of America raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price objective for the company in a report on Monday, December 15th. Jefferies Financial Group upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and upped their target price for the stock from $1,400.00 to $1,450.00 in a research report on Friday. Wells Fargo & Company increased their target price on Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the company an “equal weight” rating in a research note on Monday, December 15th. Finally, Wall Street Zen upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Saturday, February 14th.

Mettler-Toledo International Trading Up 1.3%

Shares of MTD opened at $1,205.77 on Monday. The company has a market cap of $24.42 billion, a PE ratio of 28.63, a price-to-earnings-growth ratio of 2.50 and a beta of 1.43. The stock has a 50-day moving average price of $1,351.42 and a 200-day moving average price of $1,364.72. Mettler-Toledo International has a 12-month low of $946.69 and a 12-month high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, February 5th. The medical instruments supplier reported $13.36 earnings per share for the quarter, topping the consensus estimate of $12.76 by $0.60. The company had revenue of $1.13 billion for the quarter, compared to analysts’ expectations of $1.10 billion. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. Mettler-Toledo International’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same period in the prior year, the business earned $12.41 earnings per share. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. As a group, analysts predict that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Activity at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 800 shares of the stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the transaction, the chief financial officer directly owned 5,288 shares in the company, valued at approximately $7,456,714.56. This represents a 13.14% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

A number of hedge funds have recently bought and sold shares of MTD. Reflection Asset Management bought a new position in Mettler-Toledo International during the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC bought a new stake in shares of Mettler-Toledo International in the 4th quarter worth approximately $29,000. Versant Capital Management Inc boosted its stake in shares of Mettler-Toledo International by 42.1% in the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after purchasing an additional 8 shares in the last quarter. SJS Investment Consulting Inc. grew its holdings in shares of Mettler-Toledo International by 2,700.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 27 shares during the last quarter. Finally, DV Equities LLC bought a new position in shares of Mettler-Toledo International during the 4th quarter valued at $40,000. Institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.